VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CHRS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CHRSCoherus Oncology, Inc.
$0.77$94M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCHRSPrice History

CHRS logoCoherus Oncology, Inc. (CHRS) Stock Price History

Historical prices from 2014 to 2026

$0.77+0.02  (+2.82%)close Nov 6
Returns
1M
-25.2%
3M
-38.9%
YTD
-43.8%
1Y
-48.3%
3Y
-39.9%
5Y
-46.5%
ATH$38.10Jul 2015-98.0%
ATL$0.66Nov 2024pre-split
Avg Vol (50D)1.5M/ day
52-Week Range$0.73 — $2.62
LowCurrent: $0.77High

Loading 10-year price history...

CHRS Historical Performance

1 YearTotal Return
-48.3%
Price: -48.3%
3 YearsTotal Return
-78.2%
CAGR: -39.9%
Price: -78.2%
5 YearsTotal Return
-95.6%
CAGR: -46.5%
Price: -95.6%
YTD
-43.8%

CHRS Annual Returns

Year-by-year price performance · 2014–2026

Best+97.4%2019
Worst-68.6%2017
Up years5/13
2014+29.4%
2015+45.1%
2016+33.6%
2017-68.6%
2018-5.2%
2019+97.4%
2020-5.1%
2021-5.6%
2022-51.7%
2023-60.9%
2024-56.1%
2025+1.4%
2026-21.9%
2014 annual price return
+29.4%
2015 annual price return
+45.1%
2016 annual price return
+33.6%
2017 annual price return
-68.6%
2018 annual price return
-5.2%
2019 annual price return
+97.4%
2020 annual price return
-5.1%
2021 annual price return
-5.6%
2022 annual price return
-51.7%
2023 annual price return
-60.9%
2024 annual price return
-56.1%
2025 annual price return
+1.4%
2026 annual price return
-21.9%
LessMore
Alpha vs S&P 500
1Y-58.0%
3Y-59.5%
5Y-56.2%

Price returns only.

Download Historical Data

3,018 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

CHRS Stock Price Trajectory (2014–2026)

As of November 8, 2026, Coherus Oncology, Inc. (CHRS) trades at $0.77, representing a -48.3% return over the past year. The stock has delivered a -95.6% total return over five years (-46.5% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $38.10 on July 22, 2015. From this peak, CHRS has corrected -98.0%, currently trading 49% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers PRGO (+6.2% 1Y), AMRX (+72.7% 1Y), and HCM (-1.9% 1Y), CHRS has underperformed the peer group average. Compare CHRS vs PRGO →

CHRS Historical Price Data · from 2014

Rows 1–50 of 3,018
Date Open High Low Close Volume Change %
2026-11-060.760.780.740.771.08M+2.82%
2026-11-050.850.860.730.751.74M-11.91%
2026-11-040.820.890.810.851.94M+5.54%
2026-11-030.770.820.770.812.21M+7.50%
2026-11-020.830.840.750.752.61M-9.72%
2026-10-300.900.920.820.832.19M-7.60%
2026-10-291.151.150.810.906.14M-22.55%
2026-10-281.081.171.051.161.41M+8.41%
2026-10-271.031.071.011.07606K+5.94%
2026-10-261.011.020.981.01687K0.00%
2026-10-231.031.040.991.01641K-3.81%
2026-10-221.021.061.011.05642K+2.94%
2026-10-211.011.051.001.021.28M+2.00%
2026-10-200.961.030.951.00968K+4.31%
2026-10-191.001.010.940.961.73M-3.16%
2026-10-161.071.070.990.99939K-7.48%
2026-10-151.071.091.031.071.54M+1.90%
2026-10-141.051.091.011.051.72M-1.87%
2026-10-131.061.081.001.071.34M+3.88%
2026-10-121.061.071.031.031.04M-3.74%
2026-10-091.061.121.051.071.70M0.00%
2026-10-081.011.070.971.072.14M+5.94%
2026-10-071.021.081.011.011.23M-1.94%
2026-10-061.131.131.011.032.97M-8.04%
2026-10-051.161.161.081.122.01M-3.45%
2026-10-021.191.191.151.161.18M0.00%
2026-10-011.201.211.151.16709K-4.13%
2026-09-301.181.231.161.211.58M+2.54%
2026-09-291.151.201.121.181.35M+3.51%
2026-09-281.131.151.101.141.14M+0.88%
2026-09-251.171.191.131.131.22M-3.42%
2026-09-241.251.261.171.171.57M-7.14%
2026-09-231.301.311.211.261.62M-3.08%
2026-09-221.391.391.221.304.54M-5.11%
2026-09-211.351.431.301.371.49M+1.48%
2026-09-181.231.351.231.353.12M+9.76%
2026-09-171.261.271.181.231.89M+0.82%
2026-09-161.341.351.211.221.29M-8.27%
2026-09-151.381.391.321.33762K-6.99%
2026-09-141.341.431.341.431.27M+7.52%
2026-09-111.381.381.331.33529K-0.75%
2026-09-101.331.361.301.341.02M+1.52%
2026-09-091.341.381.311.32841K-3.65%
2026-09-081.401.431.361.37549K-3.52%
2026-09-041.381.441.381.42306K+3.65%
2026-09-031.421.431.361.37437K-3.52%
2026-09-021.371.441.361.42621K+3.65%
2026-09-011.361.401.351.37695K+1.48%
2026-08-311.391.411.301.351.13M-4.26%
2026-08-281.451.481.401.41605K-3.42%
…
Consensus & Technical Research Suite
Open CHRS Terminal

CHRS Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CHRS — Frequently Asked Questions

Quick answers to the most common questions about buying CHRS stock.

How has CHRS stock performed recently?

CHRS declined -48.3% over the past year, below its 5-year annualized CAGR of -46.5%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is CHRS's all-time high price?

Coherus Oncology, Inc. reached $38.10 on 2015-07-22. The 52-week high is $2.62. Current 1-year return of -48.3% places the stock further from historical peaks.

Where can I download CHRS historical price data?

This page provides CHRS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

432 data points · sampled from 3,018